Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort study

Abstract Advances in conditioning regimens have made non‐myeloablative allogeneic hematopoietic stem cell transplantation (HSCT) a viable curative option for adults with sickle cell disease (SCD). However, prospective studies comparing pre‐ and post‐transplant patient‐reported health outcomes are sc...

Full description

Saved in:
Bibliographic Details
Main Authors: Elisabeth Dovern, Sterre J. A. M. Nijland, Annemarie M. J. Braamse, Maud M. vanMuilekom, Elisabeth M. J. Suijk, Gerianne M. Hoogendoorn, Charlotte F. J. vanTuijn, Michael R. DeBaun, Bart J. Biemond, Lotte Haverman, Erfan Nur
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:HemaSphere
Online Access:https://doi.org/10.1002/hem3.70100
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850066440504213504
author Elisabeth Dovern
Sterre J. A. M. Nijland
Annemarie M. J. Braamse
Maud M. vanMuilekom
Elisabeth M. J. Suijk
Gerianne M. Hoogendoorn
Charlotte F. J. vanTuijn
Michael R. DeBaun
Bart J. Biemond
Lotte Haverman
Erfan Nur
author_facet Elisabeth Dovern
Sterre J. A. M. Nijland
Annemarie M. J. Braamse
Maud M. vanMuilekom
Elisabeth M. J. Suijk
Gerianne M. Hoogendoorn
Charlotte F. J. vanTuijn
Michael R. DeBaun
Bart J. Biemond
Lotte Haverman
Erfan Nur
author_sort Elisabeth Dovern
collection DOAJ
description Abstract Advances in conditioning regimens have made non‐myeloablative allogeneic hematopoietic stem cell transplantation (HSCT) a viable curative option for adults with sickle cell disease (SCD). However, prospective studies comparing pre‐ and post‐transplant patient‐reported health outcomes are scarce. Therefore, in a prospective, mixed‐methods cohort study in adults with SCD undergoing HSCT, we tested the hypothesis that physical, mental, and social health improves after HSCT relative to baseline. We compared 9 Patient‐Reported Outcomes Measurement Information System (PROMIS®) measures at 6, 12, and 18 months post‐transplant to baseline and general population values. Semi‐structured interviews were conducted pre‐ and post‐transplant that were thematically analyzed (MAXQDA). Seventeen patients (7 females, 10 males; median age 26 years) underwent matched sibling (9) or haploidentical donor (8) transplantation. Compared to baseline, pain interference (p = 0.008), physical function (p < 0.001), fatigue (p = 0.001), anxiety (p = 0.016), anger (p = 0.037), and the ability to (p < 0.001) and satisfaction with (p < 0.001) social roles and activities improved at 18 months. Compared to reference values, physical function, sleep disturbance, fatigue, anxiety, and the ability to and satisfaction with social roles and activities T‐scores were significantly worse at baseline but comparable or better after 18 months. Thematic analysis of the interviews revealed high satisfaction with improved physical and social abilities alongside complex mental health challenges, including processing the psychological aftermath of SCD, dealing with transplant‐related toxicity, adjustment challenges, and identity conflicts. In conclusion, while physical, mental, and social health improves after HSCT, the effects on mental health can be complex and warrant psychosocial support early in the process of curative therapies.
format Article
id doaj-art-ee2d05c9f8bd42a382fc47d495985e86
institution DOAJ
issn 2572-9241
language English
publishDate 2025-03-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj-art-ee2d05c9f8bd42a382fc47d495985e862025-08-20T02:48:45ZengWileyHemaSphere2572-92412025-03-0193n/an/a10.1002/hem3.70100Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort studyElisabeth Dovern0Sterre J. A. M. Nijland1Annemarie M. J. Braamse2Maud M. vanMuilekom3Elisabeth M. J. Suijk4Gerianne M. Hoogendoorn5Charlotte F. J. vanTuijn6Michael R. DeBaun7Bart J. Biemond8Lotte Haverman9Erfan Nur10Department of Hematology Amsterdam UMC location University of Amsterdam Amsterdam The NetherlandsDepartment of Hematology Amsterdam UMC location University of Amsterdam Amsterdam The NetherlandsDepartment of Medical Psychology Amsterdam UMC location University of Amsterdam Amsterdam The NetherlandsDepartment of Child and Adolescent Psychiatry & Psychosocial Care, Emma Children's Hospital Amsterdam UMC location University of Amsterdam The NetherlandsDepartment of Hematology Amsterdam UMC location University of Amsterdam Amsterdam The NetherlandsDepartment of Hematology Amsterdam UMC location University of Amsterdam Amsterdam The NetherlandsDepartment of Hematology Amsterdam UMC location University of Amsterdam Amsterdam The NetherlandsDepartment of Pediatrics, Vanderbilt‐Meharry Center of Excellence in Sickle Cell Disease Vanderbilt University Medical Center Nashville Tennessee USADepartment of Hematology Amsterdam UMC location University of Amsterdam Amsterdam The NetherlandsDepartment of Child and Adolescent Psychiatry & Psychosocial Care, Emma Children's Hospital Amsterdam UMC location University of Amsterdam The NetherlandsDepartment of Hematology Amsterdam UMC location University of Amsterdam Amsterdam The NetherlandsAbstract Advances in conditioning regimens have made non‐myeloablative allogeneic hematopoietic stem cell transplantation (HSCT) a viable curative option for adults with sickle cell disease (SCD). However, prospective studies comparing pre‐ and post‐transplant patient‐reported health outcomes are scarce. Therefore, in a prospective, mixed‐methods cohort study in adults with SCD undergoing HSCT, we tested the hypothesis that physical, mental, and social health improves after HSCT relative to baseline. We compared 9 Patient‐Reported Outcomes Measurement Information System (PROMIS®) measures at 6, 12, and 18 months post‐transplant to baseline and general population values. Semi‐structured interviews were conducted pre‐ and post‐transplant that were thematically analyzed (MAXQDA). Seventeen patients (7 females, 10 males; median age 26 years) underwent matched sibling (9) or haploidentical donor (8) transplantation. Compared to baseline, pain interference (p = 0.008), physical function (p < 0.001), fatigue (p = 0.001), anxiety (p = 0.016), anger (p = 0.037), and the ability to (p < 0.001) and satisfaction with (p < 0.001) social roles and activities improved at 18 months. Compared to reference values, physical function, sleep disturbance, fatigue, anxiety, and the ability to and satisfaction with social roles and activities T‐scores were significantly worse at baseline but comparable or better after 18 months. Thematic analysis of the interviews revealed high satisfaction with improved physical and social abilities alongside complex mental health challenges, including processing the psychological aftermath of SCD, dealing with transplant‐related toxicity, adjustment challenges, and identity conflicts. In conclusion, while physical, mental, and social health improves after HSCT, the effects on mental health can be complex and warrant psychosocial support early in the process of curative therapies.https://doi.org/10.1002/hem3.70100
spellingShingle Elisabeth Dovern
Sterre J. A. M. Nijland
Annemarie M. J. Braamse
Maud M. vanMuilekom
Elisabeth M. J. Suijk
Gerianne M. Hoogendoorn
Charlotte F. J. vanTuijn
Michael R. DeBaun
Bart J. Biemond
Lotte Haverman
Erfan Nur
Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort study
HemaSphere
title Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort study
title_full Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort study
title_fullStr Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort study
title_full_unstemmed Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort study
title_short Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort study
title_sort changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation a mixed methods prospective cohort study
url https://doi.org/10.1002/hem3.70100
work_keys_str_mv AT elisabethdovern changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy
AT sterrejamnijland changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy
AT annemariemjbraamse changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy
AT maudmvanmuilekom changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy
AT elisabethmjsuijk changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy
AT geriannemhoogendoorn changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy
AT charlottefjvantuijn changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy
AT michaelrdebaun changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy
AT bartjbiemond changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy
AT lottehaverman changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy
AT erfannur changesinthequalityoflifeofadultswithsicklecelldiseasefollowingallogeneicstemcelltransplantationamixedmethodsprospectivecohortstudy